MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 215 filers reported holding MEDICINES CO in Q1 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $717,000 | +44.0% | 14,336 | +4.9% | 0.02% | +41.2% |
| Q2 2019 | $498,000 | +34.2% | 13,664 | +3.0% | 0.02% | +30.8% |
| Q1 2019 | $371,000 | +46.1% | 13,272 | 0.0% | 0.01% | +30.0% |
| Q4 2018 | $254,000 | -17.3% | 13,272 | +29.2% | 0.01% | 0.0% |
| Q3 2018 | $307,000 | +2.0% | 10,276 | +25.3% | 0.01% | 0.0% |
| Q2 2018 | $301,000 | +16.7% | 8,204 | +4.6% | 0.01% | +11.1% |
| Q1 2018 | $258,000 | +20.6% | 7,840 | 0.0% | 0.01% | +28.6% |
| Q4 2017 | $214,000 | -14.1% | 7,840 | +16.7% | 0.01% | -22.2% |
| Q3 2017 | $249,000 | +13.2% | 6,720 | +15.9% | 0.01% | +12.5% |
| Q2 2017 | $220,000 | +35.8% | 5,796 | +75.4% | 0.01% | +33.3% |
| Q1 2017 | $162,000 | +62.0% | 3,304 | +12.4% | 0.01% | +50.0% |
| Q4 2016 | $100,000 | – | 2,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |